OTC pain relief gets a boost as the FDA approves an acetaminophen‑naproxen combo, offering a new over‑the‑counter option for adults and kids twelve and older.

New drugs take time to get insurance reimbursement, with little change over the past decade in the US and Europe, affecting insurance…

OTC pain relief gets a boost as the FDA approves an acetaminophen‑naproxen combo, offering a new over‑the‑counter option…

Oncology infusion staffing trends reveal how smoother patient flow lets nurses optimize schedules, boosting efficiency and patient care…

Lung cancer remains a significant health concern with high mortality rates, emphasizing the importance of early detection and…

FDA approves expanded access to gene therapies, but internet users face blocking site errors. Explore breakthroughs and obstacles…

Discover key strategies from the 2026 Pharmacists Convention on policy and AI to enhance operations and outcomes for…

Does the time you get your flu shot matter? A new study analyzing over 23 million vaccinations reveals…

Oncology pharmacists explore ways to reduce hospitalization for step-up dosing in myeloma patients safely.

Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis in covid-19 patients with type 2 diabetes.

Learn why user access is denied after pharmacy restrictions and how independent pharmacists adapt to new wellness services.

Isatuximab approval in the EU marks the first subcutaneous Sarclisa delivery via the CirCLIQ injector, expanding multiple myeloma…